Sensory neuron transient receptor potential vanilloid-1 channel regulates angiogenesis through CGRP in vivo

Zhanfeng Zhu, Yixuan Jiang, Zixia Li, Yu Du, Qinyi Chen, Qiang Guo, Yu Ban, Ping GongFrontiers in Bioengineering and Biotechnology 2024 · DOI

Abstract

Angiogenesis is a fundamental requirement for successful bone regeneration. While peripheral nerves are known to densely innervate bone tissue, the specific molecular mechanisms by which sensory neurons influence vascularization during repair remain largely unexplored. This study investigates the role of the Transient Receptor Potential Vanilloid 1 (TRPV1) channel, a known nociceptor, in regulating angiogenesis. Using a mouse femur defect model, researchers demonstrated that neuronal TRPV1 activation enhances blood vessel volume, number, and thickness. This effect is mediated through the release of Calcitonin Gene-Related Peptide (CGRP), which subsequently upregulates angiogenic factors like VEGF-A. These findings suggest that the TRPV1-CGRP signaling axis is a critical regulator of early vascularization in bone repair, offering a potential therapeutic target for regenerative medicine.

Introduction

Effective bone healing is entirely dependent on angiogenesis—the formation of new blood vessels to transport oxygen, nutrients, and specialized cells to the site of an injury. While the presence of peripheral nerves in bone is well-documented, the functional "crosstalk" between these nerves and the vascular system during the repair process has been unclear.

This research focuses on TRPV1, a receptor typically associated with sensing heat and pain. The study aimed to determine if TRPV1 serves a broader physiological role beyond nociception: specifically, whether it actively manages the vascular environment required for bone tissue to knit back together.

Methodology

The researchers employed a mouse model featuring a standardized 1-mm femur defect. Subjects were divided into four experimental groups to isolate the effects of the TRPV1 pathway:

  • Control Group: Standard healing conditions.
  • Capsaicin Group: TRPV1 activation via intrathecal drug delivery.
  • Capsazepine Group: TRPV1 inhibition.
  • Rescue Group: TRPV1 inhibition combined with local CGRP administration.

Advanced imaging and molecular techniques were used to assess outcomes, including Micro-CT with Microfil® perfusion for 3D vascular visualization, retrograde tracing with Fluoro-gold to map neuronal connections between the spine and the femur, and Western Blotting to measure protein expression of angiogenic markers like CD31 and VEGF-A.

The TRPV1-CGRP Axis and Angiogenesis

A central finding of the study is the identification of a direct causal chain: TRPV1 activation in the Dorsal Root Ganglia (DRG) triggers the release of CGRP at nerve terminals within the bone. This neuropeptide then acts on local tissues to stimulate the production of VEGF-A (Vascular Endothelial Growth Factor A), the primary signal for vessel growth.

Immunofluorescence staining of DRG neurons showing co-localization of TRPV1 and CGRP across experimental groups. White arrows indicate increased expression in the capsaicin-treated group.

Immunofluorescence staining confirmed that TRPV1 and CGRP are co-localized within the same sensory neurons. As shown in the figure above, neurons connected to the injury site (labeled with Fluoro-gold) showed significant upregulation of both TRPV1 and CGRP when stimulated with capsaicin, whereas inhibition with capsazepine reduced these markers.

Key Results

  • Enhanced Vascular Architecture: Micro-CT analysis revealed that the capsaicin group exhibited a significantly higher Vessel Volume Fraction (VVF), along with increased vessel number and thickness compared to controls. Conversely, TRPV1 inhibition led to sparse, disconnected vascular networks.
  • Molecular Upregulation: Activation of the TRPV1 channel led to a spike in CD31 (an endothelial cell marker) and α-SMA (a smooth muscle cell marker), indicating that the induced vessels were structurally robust and functional.
  • CGRP as the Primary Effector: In mice where TRPV1 was blocked, the researchers successfully "rescued" the angiogenic process by locally injecting a CGRP-expressing lentivirus. This confirms that CGRP is the essential downstream molecule through which TRPV1 exerts its pro-angiogenic effects.

Discussion and Clinical Implications

This study redefines sensory nerves as active regulators of tissue regeneration rather than mere sensors of pain. However, the authors note the "Capsaicin Paradox": while stimulation promotes healing, excessive or prolonged doses can lead to nerve desensitization.

Future research must focus on identifying a therapeutic "Goldilocks" zone for stimulation and exploring non-invasive delivery methods. While this mouse model provides a strong proof-of-concept, translating these findings to human clinical practice will require further investigation into long-term bone mineralization and mechanical strength.

Summary updated

Abstract

Angiogenesis plays a key role in bone regeneration. The role of neurons of peripheral nerves involved in angiogenesis of bone defects needs to be explored. The transient receptor potential vanilloid 1 (TRPV1), a nociceptor of noxious stimuli, is expressed on sensory neurons. Apart from nociception, little is known about the role of sensory innervation in angiogenesis. Calcitonin gene-related peptide (CGRP), a neuropeptide secreted by sensory nerve terminals, has been associated with vascular regeneration. We characterized the reinnervation of vessels in bone repair and assessed the impact of TRPV1-CGRP signaling on early vascularization. We investigated the pro-angiogenic effect of neuronal TRPV1 in the mouse model of femur defect. Micro-CT analysis with Microfil<sup>®</sup> reagent perfusion demonstrated neuronal TRPV1 activation enhanced angiogenesis by increasing vessel volume, number, and thickness. Meanwhile, TRPV1 activation upregulated the mRNA and protein expression of vascular endothelial growth factor A (VEGF-A), cell adhesion molecule-1 (CD31), and CGRP. Immunostaining revealed the co-localization of TRPV1 and CGRP in dorsal root ganglia (DRG) sensory neurons. By affecting neuronal TRPV1 channels, the release of neuronal and local CGRP was controlled. We demonstrated that TRPV1 influenced on blood vessel development by promoting CGRP release from sensory nerve terminals. Our results showed that neuronal TRPV1 played a crucial role in regulating angiogenesis during bone repair and provided important clinical implications for the development of novel therapeutic approaches for angiogenesis.
BibTeX
@inproceedings{zhu2024sensory,
  author = {Zhanfeng Zhu and Yixuan Jiang and Zixia Li and Yu Du and Qinyi Chen and Qiang Guo and Yu Ban and Ping Gong},
  title = {{Sensory neuron transient receptor potential vanilloid-1 channel regulates angiogenesis through CGRP in vivo}},
  booktitle = {Frontiers in Bioengineering and Biotechnology},
  year = {2024},
  doi = {10.3389/fbioe.2024.1338504},
}
Figure